Application of bronchoscopic microsampling procedure for determining epithelial lining fluid cytokines in patients with ALI/ARDS Source: Annual Congress 2009 - Mechanisms of lung injury: COPD, asthma and acute lung injury Year: 2009
Predictive role of neutrophil elastase in the follow-up of patients with interstitial lung diseases Source: Eur Respir J 2001; 18: Suppl. 33, 409s Year: 2001
Neutrophil elastase and IL-8 assessment in patients with COPD and asthma Source: Eur Respir J 2005; 26: Suppl. 49, 61s Year: 2005
Towards precision medicine in bronchiectasis: what is the role of neutrophilic elastase determination? Source: Eur Respir J, 53 (6) 1900765; 10.1183/13993003.00765-2019 Year: 2019
Comparison of different techniques to evaluate active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients Source: International Congress 2019 – Complex respiratory infections in clinical practice Year: 2019
Conduct of a biomarker study in bronchiectasis patients: Correlation of neutrophil elastase activity and inflammatory load in induced sputum Source: International Congress 2014 – Systemic and airway biomarkers Year: 2014
Diagnostic implications of sTREM-1 in induced sputum and BAL fluid of patients with asthma and COPD Source: International Congress 2015 – Modulating the immune system in COPD and asthma Year: 2015
A point-of-care neutrophil elastase activity assay identifies bronchiectasis severity, airway infection and risk of exacerbation Source: Eur Respir J, 53 (6) 1900303; 10.1183/13993003.00303-2019 Year: 2019
Usefulness of selective neutrophil elastase inhibitor, sivelestat, in ALI patients with SIRS Source: Annual Congress 2012 - How to use technology to provide better critical care Year: 2012
Effects of a neutrophil elastase inhibitor against mediators of acute exacerbation of pulmonary fibrosis: a new therapeutic strategy Source: Annual Congress 2008 - New therapeutic strategies in idiopathic pulmonary fibrosis Year: 2008
Clinical applications of assessment of airway inflammation using induced sputum Source: Eur Respir J 2002; 20: 40S-43S Year: 2002
Neutrophil activity assessed using a novel serological marker of human neutrophil elastase degraded calprotectin is elevated in patients with COPD or IPF Source: Virtual Congress 2021 – Advanced in vitro models for drug discovery Year: 2021
Role of pulmonary rehabilitation after bronchoscopic treatment of emphysema Source: International Congress 2017 – Endoscopic lung volume reduction (EVLR) and targeted lung denervation (TLD) Year: 2017
Neutrophil elastase levels in sputum of patients with different airway diseases: COPD, bronchiectasis and asthma Source: Eur Respir J 2002; 20: Suppl. 38, 95s Year: 2002
Comparison of three methods for preparation of bronchiectasis sputum supernatents for biomarker measurement Source: International Congress 2015 – Bronchiectasis and NTM infections: clinical and functional characterisation Year: 2015
Diagnostic value of cryobiopsy in patients with interstitial lung diseases integrating bronchoalveolar lavage, radiologic and clinical data Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Usefulness of bronchoscopy in acute interstitial lung diseases Source: International Congress 2018 – PG6 Bronchoscopy in pulmonary emergencies Year: 2018
Elevated levels of chemokines in bronchoalveolar lavage fluid as diagnostic markers for predicting the development of post-transplant obliterative bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
Investigating optimal sputum processing methods for active neutrophil elastase quantification Source: International Congress 2017 – Techniques in biomarker selection Year: 2017
Role of sputum eosinophil levels in the assessment of asthma treatment Source: Eur Respir J 2004; 24: Suppl. 48, 579s Year: 2004